FDA Approves Genentech’s Kadcyla for Adjuvant Treatment of People with HER2-Positive Early Breast Cancer with Residual Invasive Disease After Neoadjuvant Treatment

– Approval based on data showing Kadcyla cut the risk of disease recurring by half compared to Herceptin in the adjuvant setting for specific patients with HER2-positive early breast cancer –

– Application approved under FDA’s Real-Time Oncology Review pilot program –Continue reading

First-of-its-kind microbial nursery to open on May 8th

The world’s first microbial nursery is Ferran Garcia-Pichel’s brainchild, a mobile lab designed restore arid lands in the Southwest. Garcia-Pichel is director of the Biodesign Center for Fundamental and Applied Microbiomics and professor in ASU’s School of Life Sciences. His plans to grow microbes and prevent dust pollution earned him recognition last fall as a finalist in the Governor’s Celebration of Innovation.Continue reading